Literature DB >> 1700128

Inhibition of SIV/SMM replication in vitro by CD8+ cells from SIV/SMM infected seropositive clinically asymptomatic sooty mangabeys.

J D Powell1, T Yehuda-Cohen, F Villinger, H M McClure, K W Sell, A Ahmed-Ansari.   

Abstract

Several investigators have demonstrated the ability of CD8+ T cells from HIV-1 infected humans and SIV infected rhesus macaques to inhibit viral replication in vitro. In this report we show that CD8+ cells from naturally SIV infected sooty mangabeys also have the ability to inhibit viral replication in vitro. In addition, initial experiments which seek to elucidate the mechanism and antigen specificity of CD8-mediated suppression are described.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1700128

Source DB:  PubMed          Journal:  J Med Primatol        ISSN： 0047-2565            Impact factor:   0.667


  8 in total

1.  Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease.

Authors:  A M Gómez; F M Smaill; K L Rosenthal
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

2.  Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease.

Authors:  M A Rey-Cuillé; J L Berthier; M C Bomsel-Demontoy; Y Chaduc; L Montagnier; A G Hovanessian; L A Chakrabarti
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Inhibition of cellular activation of retroviral replication by CD8+ T cells derived from non-human primates.

Authors:  J D Powell; D P Bednarik; T M Folks; T Jehuda-Cohen; F Villinger; K W Sell; A A Ansari
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

4.  Detection of occult simian immunodeficiency virus SIVsmm infection in asymptomatic seronegative nonhuman primates and evidence for variation in SIV gag sequence between in vivo- and in vitro-propagated virus.

Authors:  F Villinger; J D Powell; T Jehuda-Cohen; N Neckelmann; M Vuchetich; B De; T M Folks; H M McClure; A A Ansari
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

5.  Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories.

Authors:  F B Hollinger; J W Bremer; L E Myers; J W Gold; L McQuay
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

6.  Evidence for CD8+ antiviral activity in cats infected with feline immunodeficiency virus.

Authors:  C R Jeng; R V English; T Childers; M B Tompkins; W A Tompkins
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques.

Authors:  A Kaur; R M Grant; R E Means; H McClure; M Feinberg; R P Johnson
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

8.  HLA compatibility requirements for CD8(+)-T-cell-mediated suppression of human immunodeficiency virus replication.

Authors:  C E Mackewicz; M R Garovoy; J A Levy
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.